We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tufts: Biologics Manufacturers Need More Adaptable Strategies
Tufts: Biologics Manufacturers Need More Adaptable Strategies
Makers of biopharmaceuticals will need to become more modular and agile to adjust for trends in personalized medicine and oncology, according to the Tufts Center for the Study of Drug Development.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor